CABOZANTINIB (CABOZANTINIB) — FDA Approval ANDA213878 (MSN LABORATORIES PRIVATE LTD)
CABOZANTINIB (CABOZANTINIB) — FDA Approval ANDA213878 (MSN LABORATORIES PRIVATE LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CABOZANTINIB; Active ingredients: CABOZANTINIB; Application number: ANDA213878.
| Brand name | CABOZANTINIB |
|---|---|
| Active ingredients | CABOZANTINIB |
| Application number | ANDA213878 |
| Sponsor | MSN LABORATORIES PRIVATE LTD |
| Dosage form | TABLET |
| Marketing status | None (Tentative Approval) |
| Products in application | 2 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →